Uvavanyo oluTsha lweKlinikhi oluNxulumene noMhlaza

I-Enveric Biosciences isebenza kunye neYunivesithi yaseCalgary's Hotchkiss Brain Institute, iziko elikhokelayo le-neuroscience egqwesileyo, kwiSikolo sezoNyango saseCumming eCalgary, eCanada esizinikezele ekuqhubeleni phambili uphando lwengqondo kunye nempilo yengqondo kunye nemfundo, ukuseka uvavanyo lweklinikhi olunzima. I-EVM-101 yonyango lwe-Cancer Related Distress.

Malunga ne-50% yezigulana ezinomhlaza zichaza amanqanaba ekliniki yoxinzelelo lwengqondo olunoxinzelelo lwengqondo, ixhala, ukudakumba, ukubonakaliswa kweklinikhi okubangelwa luxinzelelo, kunye nokuncipha komgangatho wobomi. Ukuya kuthi ga kwi-40% yezigulana ezinomhlaza ziyahlangabezana nemigaqo yokuphazamiseka kweemvakalelo ezifuna unyango. I-CRD yimfuno ebalulekileyo yonyango engafezekanga kwaye akukho mvume yokulawula yangoku yee-pharmacotherapies kunye nesidingo esiphuthumayo sokwandisa umgangatho wangoku wokhathalelo lwezigulane ezinomhlaza.

Ulingo lweklinikhi, olulindeleke ukuba luqalise kamva kulo nyaka, lwe-EVM-101, unyango lwe-psychedelic yesizukulwana sokuqala, kwi-CRD luya kukhokelwa ngumphandi we-HBI, uDkt. Valerie Taylor, iNtloko yeSebe le-Psychiatry, eCalgary, eCanada. 

“Siyavuya ukusebenzisana no-Enveric ukufunda amayeza esizukulwana esilandelayo esinethemba lokuba aya kunceda abantu bajongane nemiceli mngeni yengqondo yokufunyaniswa komhlaza. Lo msebenzi uza kusivumela ukuba sihlanganise izixhobo zethu ezidityanisiweyo ukuze senze uphando ngezigulane ezinomhlaza eziphila neCRD,” utshilo uGqr. Valerie Taylor.

Uphononongo lwe-EVM-101 luya kuvavanya ngokuthe ngqo iimpawu eziphambili ze-CRD ezichaphazeleka kakhulu kwaye zikwazi ukuphuculwa emva konyango olusekelwe kwi-psilocybin.

"Ngokunyuka kwamazinga omhlaza kunye nezigulo zengqondo ezinxulumene nazo eziye zajongelwa phantsi kwaye zingaxilwanga kude kube kutshanje, sisebenza nzima ukuphuhlisa unyango olutsha olunceda izigulane zomhlaza eziphethwe yi-CRD" kusho uDkt Bob Dagher, iGosa eliyiNtloko lezoNyango lika-Enveric. "Intsebenziswano yethu neqela lophando kwiYunivesithi yaseCalgary's Hotchkiss Brain Institute kunye ne-IMPACT Clinical Trial Accelerator iya kusinceda sibonise iingenelo ezinokubakho kolu nyango lunoveli kwaye lubenze bathengise ngokukhawuleza."

Ukungeniswa okusemthethweni kwi-Health Canada kulindeleke ukuba kugqitywe kungekudala. Ukubhaliswa kwesigulana kulingo lwezonyango kulindeleke ukuba kuqale emva kwexesha ngo-2022 okanye ekuqaleni kuka-2023. Uyilo lophononongo luya kusebenzisa unyango lwengqondo olusemthethweni kunye nonyango lwengqondo olugxile kwizigulane ezinomhlaza ezine-CRD. Izigulane ziya kufumana idosi yomlomo enye ye-EVM-101 kwindawo exhasayo nge-psychotherapy ukuphucula iziphumo.